Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × NSCLC × Afatinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 32 Neoplasms 8 Breast Neoplasms 8 Head and Neck Neoplasms 4 Lung Neoplasms 3 Carcinoma, Squamous Cell 3 Adenocarcinoma 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thoracic Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Squamous Cell Cancers of the Head and Neck 1 Rhabdomyosarcoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Prostatic Neoplasms 1 Pleural Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Pleural Diseases 1 Neuroectodermal Tumors 1 Neoplasms by Site 1 Multiple Myeloma 1 Lymphoma 1 Lung Diseases 1

Interventions

Paclitaxel 2 Carboplatin 2 Albumin-Bound Paclitaxel 2 osimertinib 1 aumolertinib 1 Taxes 1 Pemetrexed 1 Gemcitabine 1 Clinical Trials, Phase I as Topic 1 Cisplatin 1 Cetuximab 1 BID protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡